US Patent Issued to Northwestern University on Aug. 12 for "Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity" (Illinois Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,566, issued on Aug. 12, was assigned to Northwestern University (Evanston, Ill.).

"Inhibition of SLC transporter activity or expression to attenuate anthracycline-induced cardiotoxicity" was invented by Paul W. Burridge (Chicago) and Tarek Magdy Shehata Mohamed (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods, pharmaceutical compositions, kits, and systems for treating or preventing cardiotoxicity in a subject undergoing treatment with an anthracycline chemotherapeutic agent. The methods, pharmaceutical compositions, kits, and systems typically include or utilize a therapeutic agent that inhibits the activity or expressi...